Polyvinylpyrrolidone-modified
CuS nanocrystals (
CuS NCs) with high photothermal conversion efficiency (46%) and pH and near-infrared (NIR) light-triggered degradation properties are a promising nanotheranostic platform for in situ magnetic resonance imaging (MRI)-guided synergistic photothermal and
photodynamic therapy. On the one hand, the (102) surface of
CuS NCs has a small bandgap based on density functional theory, which leads to high photothermal conversion efficiency. On the other hand, the S vacancy formation energy of the (102) surface is favourable. On entry into
tumor cells through endocytosis, the S2-
ions on the (102) surface of
CuS NCs can be easily oxidized under the tumor microenvironment and 808 nm
laser irradiation; then, a large amount of Cu+
ions can be released from
CuS NCs and accelerate the degradation of nanocrystals. Cu+
ions can generate
reactive oxygen species (ROS) under the tumor microenvironment and 808 nm
laser irradiation. Meanwhile, the oxidation product Cu2+
ions can be generated from the oxidized Cu+
ions and applied for in situ T1-weighted magnetic resonance imaging. Moreover, the biodegradable
CuS NCs possess a high
tumor uptake and can be rapidly excreted with a low long-term retention/toxicity. Therefore, degradable and multifunctional
CuS NCs are a safe and efficient candidate for the diagnosis and treatment of
cancer.